The Pharma Career Ladder · The medical rep · Step 7: After the visit · Lesson 7

Losing a doctor

Why they stopped, and how to find out

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

Doctors rarely tell you they have stopped prescribing.

They simply drift. The numbers soften for a few months, the rep visits a little less, and by the time anyone asks, the reason is old and the habit is gone.

How I ask reps to handle it:

  • Notice the slowdown early. Watch the trend, not one month.
  • Check the pharmacy first. Sometimes it is stock, not the doctor.
  • Ask directly: "Doctor, I noticed you use it less. Did something change?"
  • Listen without defending. Do not argue with the first answer.
  • Sort the reason: patient results, tolerability, cost to the patient, or another company's visits.
  • If he mentions a side effect, report it to drug safety (pharmacovigilance) the same day.
  • Come back with something that answers his real concern. Clinical questions go to medical affairs.

Not every doctor comes back. Every doctor remembers how you handled it.

The worst response is the most common one: visiting less because he prescribes less.

“A doctor who stopped has a reason. Your job is to hear it.”
Losing a doctor: Why they stopped, and how to find out

Lesson 7 of 7 in Step 7: After the visit, with the full guide and a checklist for this week.

More lessons in step 7: After the visit

After the visit, in RepPharma

Log a visit in seconds

The doctor, products detailed, samples and outcome, on an offline-first Android app. Visits save without signal and send when it returns.

A month of visits in seconds

Smart monthly plans are drafted from each doctor’s priority, required visit frequency and best time to visit. The manager approves in one click.

Your KPIs in your pocket

The KPIs agreed with your manager appear in your own app, so you always know where you stand.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.